Quest Diagnostics Incorporated Financials

Market Capitalization $19.43 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	20.39
Forward PE	16.72
Price to Sales TTM	$1.79
Price to Book MRQ	$2.65
Enterprise to Revenue	2.34
Enterprise to EBITDA	11.85

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-09-30
Profit Margin	8.93%
Operating Margin	14.92%
Return on Assets TTM	6.12%
Return on Equity TTM	14.35%

Income Statement

Revenue TTM	$10,849,999,872
Revenue per Share TTM	$97.09
Quarterly Revenue Growth	13.20%
Gross Profit TTM	$3,628,999,936
EBITDA	$2,129,000,000
Net Income to Common TTM	$963,000,000
Diluted EPS TTM	$8.51
Quarterly Earnings Growth YoY	8.40%

Balance Sheet

Total Cash MRQ	$435,000,000
Total Cash per Share MRQ	$3.91
Total Debt MRQ	$
Total Debt to Equity MRQ	86.52
Current Ratio MRQ	1.13
Book Value per Share MRQ	$65.39

Cash Flow

Operating Cash Flow TTM	$1,884,999,936
Levered Free Cash Flow TTM	$1,000,875,008

DGX Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	110,823,441
Float Shares	110,667,239
Avg 10 Volume	827,310
Avg 30 Volume	None
Shares Short	4,225,484
Short Ratio	3.87
Short % of Shares	4.34%
% Held by Insiders	0.40%
% Held by Institutions	99.32%

Stock Price Summary

Beta	0.62
Fifty Two Week Low	$148.70
Fifty Two Week High	$197.55
Fifty Two Week Change	12.38%
Day 50 MA	$181.99
Day 200 MA	$177.28

Dividends and Splits

Forward Annual Dividend Rate	$3.20
Forward Annual Dividend Yield	1.84%
Trailing Annual Dividend Rate	$3.15
Trailing Annual Dividend Yield	1.81%
Payout Ratio	36.97%
Dividend Date	2026-01-28
Ex Dividend Date	2026-01-13
Last Split Factor
Last Split Date	2005-06-21